PMC4832034_01
The contrast-enhanced computed tomography scan obtained on admission.. The image shows that the tumor is 36 mm in size, well-contrasted in the arterial phase, and washed out in the portal and delayed phases. (a) Plain; (b) arterial phase; (c) portal phase.
gr1.jpg
PMC4832034_01_gr1.jpg
fig0005
Contrast-enhanced computed tomography (CT) performed in July 2015 revealed that the tumor had grown to a 36-mm maximum diameter and was well enhanced in the arterial phase and washed out in the portal and delayed phases (Fig. 1).
The contrast-enhanced computed tomography scan obtained approximately two months after the first examination.. The tumor is uniform with low-density and has decreased in size. The diameter is 16 mm and no contrast enhancement can be seen. (a) Plain; (b) arterial phase; (c) portal phase.
gr2.jpg
PMC4832034_01_gr2.jpg
fig0010
C virus antibody test results were negative. Both Child-Pugh and Liver Damage classifications were categorized as A. CT imaging was performed two months later (Fig. 2).
The macroscopic and histological images of the resected specimen. (a) The tumor is reddish and encapsulated with a thick fibrous capsule. (b) Hematoxylin-eosin stain, magnification x50.. Histopathological findings show only granulation and necrotic tissue, accompanied by bleeding, hemosiderosis, and dense infiltrates of inflammatory cells.
gr3.jpg
PMC4832034_01_gr3.jpg
fig0015
Histopathological findings showed granulation tissue and necrotic tissue, accompanied by bleeding, hemosiderosis, and dense infiltrates of inflammatory cells (Fig. 3).